BioInvent and Transgene receive IND approval from the U.S. FDA for BT-001, a novel oncolytic virus for the treatment of solid tumors ...Middle East

LUND, Sweden and STRASBOURG, France, May 27, 2021 /PRNewswire/ -- BioInvent International AB ("BioInvent") (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, and Transgene...

Hence then, the article about bioinvent and transgene receive ind approval from the u s fda for bt 001 a novel oncolytic virus for the treatment of solid tumors was published today ( Thursday 27/05/2021 - 10:00 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BioInvent and Transgene receive IND approval from the U.S. FDA for BT-001, a novel oncolytic virus for the treatment of solid tumors )

Also on site :

• UK to list 65-year-olds as reservists amid Russia threat claims – Telegraph
• AI boom fuels fears of an industry bubble (VIDEO)
• Amazon Has 'Super Warm' and ‘Soft' Mini Sheepskin Boots on Sale for $50, and They're 'Worth Every Penny'